City

Miami (1)

New York (1)

Condition

Advanced Myelodysplastic Syndromes (2)

AML (1)

Acute Myelogenous Leukemia (1)

Acute Myeloid Leukemia (1)

MDS (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Justin Watts, MD (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Takeda (1)

Intervention

busulfan, melphalan, fludarabine, anti-thymocyte globulin, palifermin, stem cell transplant (1)

cytarabine (1)

pevonedistat (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

advanced myelodysplastic syndromes

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

Completed

Acute Myelogenous Leukemia
+3 more

Miami, Florida

University of Miami

Dec 7, 2021

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed

Has Results

Acute Myeloid Leukemia
Advanced Myelodysplastic Syndromes

Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant

New York, New York

Memorial Sloan-Kettering Cancer Center

Aug 27, 2021